share_log

Why Hunan Copote Science TechnologyLtd's (SHSE:600476) Healthy Earnings Aren't As Good As They Seem

Why Hunan Copote Science TechnologyLtd's (SHSE:600476) Healthy Earnings Aren't As Good As They Seem

爲什麼湖南科力遠圖文科技有限公司(SHSE:600476)的盈利看起來沒有那麼好
Simply Wall St ·  09/06 18:15

Hunan Copote Science Technology Co.,Ltd. (SHSE:600476) posted some decent earnings, but shareholders didn't react strongly. Our analysis suggests they may be concerned about some underlying details.

湖南科波特科技股份有限公司, Ltd.(上海證券交易所代碼:600476)公佈了一些不錯的收益,但股東們的反應並不強烈。我們的分析表明,他們可能會擔心一些潛在的細節。

big
SHSE:600476 Earnings and Revenue History September 6th 2024
SHSE: 600476 收益和收入歷史記錄 2024 年 9 月 6 日

Zooming In On Hunan Copote Science TechnologyLtd's Earnings

放大湖南科波特科技有限公司的收益

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

在高級財務中,用於衡量公司將報告的利潤轉化爲自由現金流(FCF)的關鍵比率是應計比率(來自現金流)。爲了獲得應計比率,我們首先從一段時期的利潤中減去FCF,然後將該數字除以該期間的平均運營資產。你可以將現金流的應計比率視爲 「非FCF利潤率」。

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

這意味着負應計比率是一件好事,因爲它表明該公司帶來的自由現金流超過了其利潤所暗示的水平。這並不意味着我們應該擔心應計比率爲正,但值得注意的是,應計比率相當高的地方。那是因爲一些學術研究表明,高應計比率往往會導致利潤下降或利潤增長減少。

Over the twelve months to June 2024, Hunan Copote Science TechnologyLtd recorded an accrual ratio of 0.62. Statistically speaking, that's a real negative for future earnings. And indeed, during the period the company didn't produce any free cash flow whatsoever. Even though it reported a profit of CN¥16.8m, a look at free cash flow indicates it actually burnt through CN¥262m in the last year. It's worth noting that Hunan Copote Science TechnologyLtd generated positive FCF of CN¥11m a year ago, so at least they've done it in the past. However, we can see that a recent tax benefit, along with unusual items, have impacted its statutory profit, and therefore its accrual ratio. The good news for shareholders is that Hunan Copote Science TechnologyLtd's accrual ratio was much better last year, so this year's poor reading might simply be a case of a short term mismatch between profit and FCF. Shareholders should look for improved cashflow relative to profit in the current year, if that is indeed the case.

在截至2024年6月的十二個月中,湖南科波特科技有限公司的應計比率爲0.62。從統計學上講,這對未來的收益來說確實是負面的。事實上,在此期間,該公司沒有產生任何自由現金流。儘管該公司報告的利潤爲1680萬元人民幣,但看一下自由現金流就會發現,去年它實際上消耗了26200萬元人民幣。值得注意的是,湖南科波特科技有限公司一年前創造了1100萬元人民幣的正FCF,因此至少他們過去曾這樣做過。但是,我們可以看到,最近的稅收優惠以及不尋常的項目影響了其法定利潤,因此影響了應計比率。對股東來說,好消息是,湖南科波特科技有限公司去年的應計比率要好得多,因此今年的糟糕數據可能只是利潤與FCF之間短期不匹配的情況。如果確實如此,股東應尋求在本年度的現金流相對於利潤的改善。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Hunan Copote Science TechnologyLtd.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對湖南科波特科技有限公司的資產負債表分析

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

The fact that the company had unusual items boosting profit by CN¥2.0m, in the last year, probably goes some way to explain why its accrual ratio was so weak. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

該公司去年有不尋常的項目將利潤提高了200萬元人民幣,這一事實可能在某種程度上可以解釋其應計比率爲何如此疲軟。雖然獲得更高的利潤總是件好事,但來自不尋常物品的巨額捐款有時會抑制我們的熱情。我們統計了全球大多數上市公司的數字,不尋常的物品在自然界中很常見。而且,畢竟,這正是會計術語的含義。假設這些不尋常的項目在本年度不會再次出現,因此我們預計明年的利潤將疲軟(也就是說,在業務沒有增長的情況下)。

An Unusual Tax Situation

不尋常的稅收狀況

In addition to the notable accrual ratio, we can see that Hunan Copote Science TechnologyLtd received a tax benefit of CN¥2.1m. It's always a bit noteworthy when a company is paid by the tax man, rather than paying the tax man. We're sure the company was pleased with its tax benefit. And since it previously lost money, it may well simply indicate the realisation of past tax losses. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. In the likely event the tax benefit is not repeated, we'd expect to see its statutory profit levels drop, at least in the absence of strong growth. While we think it's good that the company has booked a tax benefit, it does mean that there's every chance the statutory profit will come in a lot higher than it would be if the income was adjusted for one-off factors.

除了顯著的應計比率外,我們可以看到湖南科波特科技有限公司獲得了210萬元人民幣的稅收優惠。當公司由納稅人支付工資而不是向納稅人付款時,總是有點值得注意的。我們確信該公司對其稅收優惠感到滿意。而且,由於它此前曾虧損,這很可能只是表明過去的稅收損失已經實現。但是,細節上的問題在於,此類福利僅在預訂當年有影響,而且本質上通常是一次性的。如果稅收優惠可能不重演,我們預計其法定利潤水平將下降,至少在沒有強勁增長的情況下是如此。儘管我們認爲公司獲得稅收優惠是件好事,但這確實意味着法定利潤很有可能遠高於根據一次性因素調整收入時的法定利潤。

Our Take On Hunan Copote Science TechnologyLtd's Profit Performance

我們對湖南康波特科技有限公司盈利表現的看法

Summing up, Hunan Copote Science TechnologyLtd's tax benefit and unusual items boosted its statutory profit leading to poor cash conversion, as reflected by its accrual ratio. For all the reasons mentioned above, we think that, at a glance, Hunan Copote Science TechnologyLtd's statutory profits could be considered to be low quality, because they are likely to give investors an overly positive impression of the company. So while earnings quality is important, it's equally important to consider the risks facing Hunan Copote Science TechnologyLtd at this point in time. You'd be interested to know, that we found 2 warning signs for Hunan Copote Science TechnologyLtd and you'll want to know about them.

總而言之,湖南科波特科技有限公司的稅收優惠和特殊項目提高了其法定利潤,導致現金轉換不佳,其應計比率反映了這一點。出於上述所有原因,我們認爲,乍一看,湖南科波特科技有限公司的法定利潤可以被認爲是低質量的,因爲它們可能會給投資者帶來過於積極的公司印象。因此,儘管收益質量很重要,但考慮湖南科波特科技有限公司目前面臨的風險同樣重要。你可能會有興趣知道,我們發現了湖南科波特科技有限公司的兩個警告標誌,你會想知道它們的。

Our examination of Hunan Copote Science TechnologyLtd has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

我們對湖南科波特科技有限公司的審查側重於某些可能使其收益看起來好於實際的因素。而且,在此基礎上,我們有些懷疑。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 「關注資金」,尋找內部人士正在買入的股票。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份擁有大量內幕持股的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論